Dear Doctor letter on Invirase®: QT-prolongations
2010.07.15
Active substance: saquinavir
Additional safety information on the arrhythmogenic risk due to QT and PR interval prolongations in association with Invirase (saquinavir).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN